Skip to Main Content

Clinical Research

Clinical trials depend on volunteers from the community.  Samaritan’s clinical research team works with hundreds of patients in the mid-Willamette Valley, connecting them with cutting-edge research through our local principal investigators. The advancement of medicine would not be possible without the continued participation of patients in clinical research.

Samaritan’s clinical research program was established in 2008. Sponsors have included: Pfizer, Boehringer Ingelheim, Spectrum, Celgene, Genentech, Amgen, Genentech, Tragara, Bracco Diagnostic, Eisai, PUMA, Novartis, Incyte, Pharmatech, Medtronic, St. Jude Medical and the National Institutes of Health.

  • National Institute of Health and Federal Drug Administration registration number: IRB00005278.
  • Institutional Organization Number (IORG) is IORG0004448.
  • We are a research affiliate of UCSF for The Alliance for Clinical Trials in Oncology.

For more information, email clinicalresearch@samhealth.org or call 541-768-4352.

 

Current Studies

Title More Information

Blood Purification for the Treatment of Pathogen Associated Shock (PURIFY-RCT)

Principal Investigator: Brian Delmonaco, MD

For more information on this trial.

A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects

Principal Investigator: Brian Delmonaco, MD

For more information on this trial.

COVID-19 Specimen Biobank

Principal Investigator: Brian Delmonaco, MD

Email clinicalresearch@samhealth.org

Breast

Title More Information

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

Principal Investigator: Rachel Shirley, DO

For more information on this trial.


Lung

Title More Information

Lung Cancer Screening Program

Principal Investigator: Vanessa Mizak, NP, and Norman Yeh, MD

Email:  clinicalresearch@samhealth.org

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Principal Investigator: John Strother, MD

For more information on this trial.

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study

Principal Investigator: John Strother, MD

For more information on this trial.

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Principal Investigator: John Strother, MD

For more information on this trial.


Other

Title More Information

Detecting Cancers Earlier Through Elective Plasma-based Cancer SEEK Testing (ASCEND)

Principal Investigator: John Strother, MD

For more information on this trial.
Multiple Metastatic Tumors

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

Principal Investigator: John Strother, MD

For more information on this trial.
Sarcoma

Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds

Principal Investigator: Nicholas Tedesco, DO

For more information on this trial.
Orthopedic Tumor Surgery

Orthopedic Tumor Data Registry

Principal Investigator: Nicholas Tedesco, DO

Email:  clinicalresearch@samhealth.org
Cancer & COVID

ASCO Survey on COVID-19 in Oncology (ASCO) Registry

Principal Investigator: Nicholas Tedesco, DO

For more information on this trial.

realMIND: Observational Study of Patients With Relapsed or Refractory DLBCL Starting Second- or Third-line Therapy (realMIND)

Principal Investigator: Robert Davis, MD

For more information on this trial.

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Principal Investigator: John Strother, MD

For more information on this trial.

 


 

Title More Information

Multi-Center, Multi-National, Open Label, Safety Study of Etripamil Nasal Spray for Patients with Paroxysmal Supraventricular Tachycardia

Principal Investigator: Jeff Hsing, MD

For more information on this trial.

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)

Principal Investigator: Jeremy Warner, DO

For more information on this trial.

 

Title More Information

A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)

Principal Investigator: Jonathan Jones, MD

For more information on this trial.

Corrona Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry

Principal Investigator: Jonathan Jones, MD

 For more information on this trial.

Rheumatology Biorepository

Principal Investigator: Jonathan Jones, MD

 For more information on this trial.

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

Principal Investigator: Jonathan Jones, MD

 For more information on this trial.

 

Title More Information

Benign Soft Tissue Tumor Resection

Principal Investigators: Jared Sanderford, DO, and Nicholas Tedesco, DO

Email: clinicalresearch@samhealth.org

Serum Cobalt and Chromium Levels

Principal Investigator:  Taylor Harris, DO, and Nicholas Tedesco, DO

Email: clinicalresearch@samhealth.org

For more information about clinical research at Samaritan, contact us at 541-768-4352 or clinicalresearch@samhealth.org.